AgeX Therapeutics, Inc. (AGE)
NYSE American - NYSE American Delayed price. Currency in USD
Add to watchlist
At close: 01:51PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 26.56M |
| Enterprise value | 36.98M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 758.78 |
| Price/book (mrq) | 12.96 |
| Enterprise value/revenue | 1.06k |
| Enterprise value/EBITDA | -4.78 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.52 |
| 52-week change 3 | -44.00% |
| S&P500 52-week change 3 | -5.62% |
| 52-week high 3 | 1.3900 |
| 52-week low 3 | 0.5160 |
| 50-day moving average 3 | 0.6819 |
| 200-day moving average 3 | 0.7579 |
Share statistics
| Avg vol (3-month) 3 | 28.57k |
| Avg vol (10-day) 3 | 19.92k |
| Shares outstanding 5 | 37.94M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 18.45M |
| % held by insiders 1 | 43.48% |
| % held by institutions 1 | 17.66% |
| Shares short (14 Jul 2022) 4 | 315.83k |
| Short ratio (14 Jul 2022) 4 | 11.2 |
| Short % of float (14 Jul 2022) 4 | 1.47% |
| Short % of shares outstanding (14 Jul 2022) 4 | 0.83% |
| Shares short (prior month 14 Jun 2022) 4 | 324.42k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 30 Mar 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -8,384.95% |
Management effectiveness
| Return on assets (ttm) | -165.89% |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | 93k |
| Revenue per share (ttm) | 0.00 |
| Quarterly revenue growth (yoy) | -91.10% |
| Gross profit (ttm) | 125k |
| EBITDA | -7.67M |
| Net income avi to common (ttm) | -9.29M |
| Diluted EPS (ttm) | -0.2450 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 448k |
| Total cash per share (mrq) | 0.01 |
| Total debt (mrq) | 10.87M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 0.18 |
| Book value per share (mrq) | -0.30 |
Cash flow statement
| Operating cash flow (ttm) | -6.86M |
| Levered free cash flow (ttm) | -1.69M |
© 2022 Yahoo. All rights reserved.
